MCSCs-exosomes对成年大鼠心肌细胞缺氧损伤的干预作用
收稿日期: 2014-07-09
网络出版日期: 2014-12-04
基金资助
东莞市科技计划资助项目（2013108101050），广东省科技计划项目（2013B021800068）
Effect of the exosomes from marrow-derived cardiac stem cells on apoptosis in the ischemia and hypoxia injured myocardial cells from adult rats
Received date: 2014-07-09
Online published: 2014-12-04
目的 探讨来源于骨髓源性心肌干细胞的外切体（MCSCs-exosomes）对成年大鼠心肌细胞体外缺氧损伤诱导凋亡的干预作用。 方法 将体外培养的成年大鼠心肌细胞随机分为对照组、缺氧组和MCSCs-exosomes预处理组。随后进行形态学观察、细胞计数，蛋白质印迹法检测凋亡相关蛋白（Bcl-2，bax）的表达变化，流式细胞仪检测凋亡率的变化。 结果 与对照组相比，缺氧组细胞凋亡相关指标均明显升高，细胞计数下降（P<0.01），Bcl-2/bax 表达下调（P<0.01），凋亡细胞比例明显增多。而MCSCs-exosomes预处理组可明显改善缺血缺氧损伤时的细胞活力，上调Bcl-2/bax的表达，降低凋亡细胞的比例（P均＜0.05）。 结论 MCSCs-exosomes预处理可以明显改善体外培养缺氧损伤诱导的成年大鼠心肌细胞的凋亡情况，其机制可能是通过抗凋亡途径减轻缺氧时细胞的损伤。
崔晓军 , 张剑凯 , 张智 , 周丽娜 , 郭金华 , 王晓红 , 马颖蓝 . MCSCs-exosomes对成年大鼠心肌细胞缺氧损伤的干预作用[J]. 中国临床解剖学杂志, 2014 , 32(6) : 685 -689 . DOI: 10.13418/j.issn.1001-165x.2014
Objective To observe the apoptosis of injured adult rats myocardial cells induced by ischemia and hypoxia in vitro and the biological functions of the exosomes from marrow-derived cardiac stem cells (MCSCs-exosomes)．Methods Cultured adult rats myocardial cells were divided into the control group，the ischemia-hypoxia group and the MCSCs-exosomes pretreated group． In vitro，we counted the cells and detected the expression of Bcl-2，bax by Western Blotting．The cell cycles and apoptosis were measured by flow cytometry． Results Compared with the control group，the model group showed lower cell counts(P<0.01) and higher apoptosis ratio． We also observed that the expression of Bcl-2 / bax was decreased(P<0.01) and the cell cycle was blocked at S phase．Compared with the ischemia-hypoxia group，MCSCs-exosomes pretreated groups showed apparent tolerance to ischemic and hypoxic injury in vitro，which manifested a higher cell viability，lower apoptosis ratio，increased expression of Bcl-2/bax and relief of the block of S phase( all P<0.05)． Conclusions Ischemia and hypoxia could cause the apoptosis of cells in vitro.MCSCs-exosomes exhibited anti-apoptosis ability in vitro．All these may provide experimental evidences for the mechanisms of MCSCs-exosomes in therapy of tissue injury．
[1] Jariwala P, Chandra S. Diagnosis and management of failed thrombolytic therapy for acute myocardial infarction
[J]. Indian Heart J, 2010, 62(1):21-28.
[2] Prasad A, Herrmann J. Myocardial infarction due to percutaneous coronary intervention
[J]. N Engl J Med, 2011, 364(5): 453-464.
[3] Mirotsou M, Jayawardena TM, Schmeckpeper J, et al. Paracrine mechanisms of stem cell reparative and regenerative actions in the heart
[J].Journal of Molecular and Cellular Cardiology, 2011; 50(2): 280-289.
[4] Menasche´ P. Stem cell therapy for chronic heart failure. Lessons from a 15-year experience
[J]. Comptes Rendus Biologies，2011, 334 (5) 489-496.
[5] Cui XJ, Wang HJ, Guo HD, et al. Transplantation of mesenchymal stem cells preconditioned with diazoxide, a mitochondrial ATP-sensitive potassium channel opener, promotes repair of myocardial infarction in rats
[J]. Tohoku J Exp Med, 2010, 220 (1):139-147.
[6] Cui XJ, Xie H, Wang HJ, et al. Transplantation of mesenchymal stem cells with self-assembling polypeptide scaffolds is conducive to treating myocardial infarction in rats
[J]. Tohoku J Exp Med, 2010, 220(4), 281-289.
[7] Lai RC, Arslan F, Lee MM, et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury
[J].Stem Cell Res, 2010, 4( 3) : 214-222．
[8] Lai RC, Chen TS, Lim SK. Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease
[J]. Regen Med, 2011, 6( 4) : 481-492．
[9] Timmers L, Lim SK, Arslan F, et al． Reduction of myocardial infract size by human mesenchymal stem cell conditioned medium
[J]. Stem cell Res, 2007, 1(2) : 129-137．
[10]Simons M, Raposo G. Exosomes-vesicular carriers for intercellular communication
[J]. Curr Opin Cell Biol, 2009, 21(4): 575- 581．
[11]Chen TS, Lai RC, Lee MM, et al. Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs
[J].Nucleic Acids Res, 2010, 38(1) : 215-224．
/
| 〈 |
|
〉 |
京ICP备08002354号-3
